INGHILLERI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 438
EU - Europa 284
AS - Asia 211
AF - Africa 1
SA - Sud America 1
Totale 935
Nazione #
US - Stati Uniti d'America 434
CN - Cina 167
IE - Irlanda 126
FI - Finlandia 50
SG - Singapore 38
DE - Germania 35
IT - Italia 30
UA - Ucraina 25
SE - Svezia 8
GB - Regno Unito 6
CA - Canada 4
JP - Giappone 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BR - Brasile 1
CZ - Repubblica Ceca 1
FR - Francia 1
IN - India 1
MU - Mauritius 1
PL - Polonia 1
RU - Federazione Russa 1
VN - Vietnam 1
Totale 935
Città #
Dublin 126
Chandler 112
Jacksonville 42
Beijing 36
Ashburn 31
Helsinki 31
Nanjing 30
Singapore 29
New York 27
Boardman 23
Wilmington 19
Pavia 17
Shenyang 17
Lawrence 16
Medford 16
Princeton 16
Shanghai 15
Jiaxing 14
Hebei 13
Ann Arbor 12
Changsha 11
Nanchang 10
Hangzhou 6
Woodbridge 5
Falls Church 4
Houston 4
Los Angeles 4
Tianjin 4
Norwalk 3
Seattle 3
Toronto 3
Des Moines 2
Milan 2
Ningbo 2
Padova 2
Piscataway 2
Tokyo 2
Torino 2
Washington 2
Baku 1
Bangshal 1
Brno 1
Busto Arsizio 1
Chuzhou 1
Fairfield 1
Falkenstein 1
Fuzhou 1
Guangzhou 1
Guarulhos 1
Gunzenhausen 1
Hanoi 1
Jiangmen 1
London 1
Ottawa 1
Pune 1
Taizhou 1
Tappahannock 1
Verona 1
Wuhan 1
Totale 735
Nome #
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction 101
Activation of Oncogenic Pathways in Idiopathic Pulmonary Fibrosis. 92
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 82
Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study. 70
Large-cell lung carcinoma with basaloid architecture and neuroendocrine differentiation: a new type of combined large-cell neuroendocrine carcinoma. 63
MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer 62
The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? 61
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells. 60
Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fibrosis. 56
Unexpected responses to EGFR inhibition in NSCLC 53
Identification of miRNAs Potentially Involved in Bronchiolitis Obliterans Syndrome: A Computational Study 52
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 49
5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin 49
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: An in vitro study 44
Peripheral CD19+CD24highCD38high B-regulatory cells in lung transplant recipients 41
miRNAs Potentially Involved in Post Lung Transplant-Obliterative Bronchiolitis: The Role of miR-21-5p 40
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma 1
Totale 976
Categoria #
all - tutte 4.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.504


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202054 0 0 0 0 0 0 6 6 0 20 22 0
2020/202159 7 5 3 8 0 6 2 10 2 9 6 1
2021/202290 17 0 2 2 3 2 2 8 4 4 8 38
2022/2023322 40 34 0 26 30 20 0 13 148 2 6 3
2023/2024151 23 26 6 5 10 46 6 11 0 3 4 11
2024/202579 13 16 9 8 3 30 0 0 0 0 0 0
Totale 976